Global Clinical Mass Spectrometry Market 2019-2023
About this market
Increase in the use of hyphenated technology will drive growth in the market. Personalized medicine refers to providing medical treatment according to the individual characteristics of patients. Personalized medicine, a multi-faceted approach to patient care, improves the ability to diagnose and treat disease and offers the potential to detect diseases at an earlier stage when treatment can be effective. Technavio’s analysts have predicted that the clinical mass spectrometry market will register a CAGR of almost 8% by 2023.
Rise in aging population
The global clinical mass spectrometry market is observing a boost in demand due to the surge in average age due to the rising life expectancy leading to a larger aging population across the globe.
High cost of instrument
Clinical mass spectrometry technologies with specific and advanced features are expensive to procure and maintain, which can restrict their adoption. Thus, this cost of instrumentation is likely to hamper the growth of the market.
For the detailed list of factors that will drive and challenge the growth of the clinical mass spectrometry market during the 2019-2023, view our report.
The market appears to be fragmented and with the presence of several companies including Agilent Technologies and Bruker the competitive environment is quite intense. Factors such as the increase in the use of hyphenated technology and rise in aging population, will provide considerable growth opportunities to clinical mass spectrometry manufactures. Agilent Technologies, Bruker, PerkinElmer, Thermo Fisher Scientific, Waters, and Danaher are some of the major companies covered in this report.
‘With the presence of a considerable number of companies, this market appears to be fragmented. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.’